fda tirzepatide decision to reconsider removal of Eli Lilly weight loss drug from shortage list US FDA delays two drug

GLP-1 medications like semaglutide have shown remarkable efficacy for weight management, with clinical trials demonstrating up to 22% body weight reduction over 68 weeks

This guidance applies to all retatrutide use, but it is especially important for alternative dosing schedules

However, 'better' on paper does not always mean 'better' for every individualsome patients tolerate semaglutide's single-pathway mechanism more comfortably

Many patients starting Zepbound (tirzepatide) for weight management wonder about potential side effects, including whether the medication causes increased sweating

Patientory has announced the launch of its new telehealth service, which will offer customized coaching that incentivizes health habits, alongside GLP-1 prescriptions, like Semaglutide